BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Budroni S, Buricchi F, Cavallone A, Bourguignon P, Caubet M, Dewar V, D'Oro U, Finco O, Garçon N, El Idrissi M, Janssens M, Leroux-Roels G, Marchant A, Schwarz T, Van Damme P, Volpini G, van der Most R, Didierlaurent AM, Burny W. Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants. NPJ Vaccines 2021;6:78. [PMID: 34021167 DOI: 10.1038/s41541-021-00337-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 O'Hagan DT, van der Most R, Lodaya RN, Coccia M, Lofano G. "World in motion" - emulsion adjuvants rising to meet the pandemic challenges. NPJ Vaccines 2021;6:158. [PMID: 34934069 DOI: 10.1038/s41541-021-00418-0] [Reference Citation Analysis]
2 Ritzau-Jost J, Hutloff A. T Cell/B Cell Interactions in the Establishment of Protective Immunity. Vaccines (Basel) 2021;9:1074. [PMID: 34696182 DOI: 10.3390/vaccines9101074] [Reference Citation Analysis]
3 Dubé C, Paris-Robidas S, Primakova I, Destexhe E, Ward BJ, Landry N, Trépanier S. Lack of effects on female fertility or pre- and postnatal development of offspring in rats after exposure to AS03-adjuvanted recombinant plant-derived virus-like particle vaccine candidate for COVID-19. Reprod Toxicol 2021;107:69-80. [PMID: 34838689 DOI: 10.1016/j.reprotox.2021.11.006] [Reference Citation Analysis]
4 Chabot A, Senti G, Erdmann I, Prinz BM, Wüthrich B, Šošić L, Kündig TM, Johansen P. Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans. Front Allergy 2022;3:832010. [DOI: 10.3389/falgy.2022.832010] [Reference Citation Analysis]